Evidence map›Paper›PMID 28370904›Full record

ArticleJournal of evaluation in clinical practice2017

Repeat prescribing of medications: A system-centred risk management model for primary care organisations.

Julie Price, Shu Ling Man, Stephen Bartlett, Kate Taylor, Mark Dinwoodie, Paul Bowie

Abstract read
In one paragraph

Article in Journal of evaluation in clinical practice, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Evaluation and pharmacists perspective of repeat prescribing process in refill clinics.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Julie PriceMedical Protection Society, Leeds, UK.
Shu Ling ManNHS Lambeth Clinical Commissioning Group, London, UK.
Stephen BartlettInvigilatis, London, UK.
Kate TaylorMedical Protection Society, Leeds, UK.
Mark DinwoodieMedical Protection Society, Leeds, UK.
Paul BowieInstitute of Health and Wellbeing, University of Glasgow, UK.ORCID http://orcid.org/0000-0001-6027-2559

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RATIONALE, AIMS AND

objectivesReducing preventable harm from repeat medication prescriptions is a patient safety priority worldwide. In the United Kingdom, repeat prescriptions items issued has doubled in the last 20 years from 5.8 to 13.3 items per patient per annum. This has significant resource implications and consequences for avoidable patient harms. Consequently, we aimed to test a risk management model to identify, measure, and reduce repeat prescribing system risks in primary care.

methodsAll 48 general medical practices in National Health Service (NHS) Lambeth Clinical Commissioning Group (an inner city area of south London in England) were recruited. Multiple interventions were implemented, including educational workshops, a web-based risk monitoring system, and external reviews of repeat prescribing system risks by clinicians. Data were collected via documentation reviews and interviews and subject to basic thematic and descriptive statistical analyses.

resultsAcross the 48 participating general practices, 62 unique repeat prescribing risks were identified on 505 occasions (eg, practices frequently experiencing difficulty interpreting medication changes on hospital discharge summaries), equating to a mean of 8.1 risks per practice (range: 1-33; SD = 7.13). Seven hundred sixty-seven system improvement actions were recommended across 96 categories (eg, alerting hospitals to illegible writing and delays with discharge summaries) with a mean of 15.6 actions per practice (range: 0-34; SD = 8.0).

conclusionsThe risk management model tested uncovered important safety concerns and facilitated the development and communication of related improvement recommendations. System-wide information on hazardous repeat prescribing and how this could be mitigated is very limited. The approach reported may have potential to close this gap and improve the reliability of general practice systems and patient safety, which should be of high interest to primary care organisations internationally.

Indexed as

PolypharmacyDrug PrescriptionsEducation, Medical, ContinuingGeneral PracticeGuideline AdherenceHumansPatient SafetyPractice Guidelines as TopicPractice Patterns, Physicians'Quality of Health CareRisk AssessmentRisk ManagementState MedicineUnited Kingdominformation technologymedication safetypatient safetyprimary carerisk management

Identifiers

PMID28370904
PMCPMC5763272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.